Report: Houstonians lose days-worth of time each year due to rush hour

not in the fast lane

Here's how much time Houstonians spend in traffic. Photo via Getty Images

Traffic is a part of life in Houston. But a new study quantifies just how much time the average Bayou City dweller spends sitting in rush hour gridlock every year—and the results are eye opening.

According to a study released this month by CoPilot, Houstonians lose nearly four days of time each year due to rush hour commuting.

The report found that rush hour extends Houstonians' commute by an extra 22 minutes per day. Annually, that totaled an additional 91.6 hours commuting due to rush hour.

This earned the Houston area (including the Woodlands and Sugar Land) a No. 8 spot on CoPilot's list of cities where commuters lose the most time to rush hour.

Evening commutes saw the highest increase in time in Houston, with the average commuter spending 14 additional minutes on roadways due to rush hour. Morning rush hour in Houston added about eight minutes to commuters' daily drives.

Houston was the only Texas city to make CoPilot's list of the top 15 cities that lost the most time to rush hour traffic. New York drivers lost the most time to rush hour, which adds about 32 minutes to daily commutes and 132 hours a year, according to the report. Los Angeles drivers lost the second-most time, followed by urban Honolulu, Miami, Baton Rouge, Louisiana; and Birmingham, Alabama.

The report found that drivers in Houston spend about eight more minutes commuting during rush hour than the average driver in the county. That totals to about 30 more hours per year than the average U.S. driver.

Commute times have been dropping nationally, reaching a low of 25.6 minutes in 2021 compared to 27.6 minutes in 2019, as more workers have transitioned to hybrid schedules or working from home, according to CoPilot

In 2020, Houston drivers even witnessed a 33 percent drop in traffic compared to in 2019, according to a study from Rice.

Still, Houston roadways are consistently ranked among the most congested in the country. Last year, a similar study found that the typical Houston driver wasted 46 hours due to traffic congestion.

Portions of the 610 West Loop are notorious for being ranked as the state's most congested roadways, and other stretches of roads are known as some of the worst bottlenecks in Texas.

Houstonians gained valuable time on the road in 2020. Photo by LUNAMARINA/Getty Images

New study drives home how drastically Houston traffic dropped in 2020

data-driven

Houstonians are still gauging all that they have lost during the pandemic, but one thing they gained in 2020 was time — specifically, in traffic.

Drivers who noticed less cars on the roads were witnessing a 33 percent drop in traffic in 2020, compared to 2019. That data comes courtesy of a new study by Rice University's Kinder Institute for Urban Research.

Houston traffic congestion levels dropped from 24 percent to an impressive 16 percent during the pandemic. In April, during the peak of area stay-at-home efforts, Houston's congestion level plummeted to 6 percent, the lowest of the year. February saw the highest congestion level of 2020 at 26 percent.

For some perspective, in 2019, a 30-minute took an extra 37.5 minutes than a trip during less congested conditions, the study notes.

Further illustrating the headache of 2019 commuting, local drivers lost some 119 hours of extra travel time during peak hours. The study also found that in 2019, Houston drivers lost 119 hours of extra travel time driving during peak hours.

Compare that to 2020, where local drivers lost a mere 71 hours of travel time, which is two full days less than 2019. What can one do with an extra two days? Besides the obvious Netflix and chill option, that savings offers enough time to read 3,588 pages of Marcel Proust's 4,211-page whopper, In Search of Lost Time, the study notes.

Less cars on the road was extremely beneficial for the environment, the study adds. U.S. greenhouse gas emission from energy and industry dropped more than 10 percent in 2020 — the lowest recorded level in 30 years.

Thus, the good news is that with more Houstonians working from home, commute times and the local environment benefitted. However, the study notes that with the advent of COVD vaccinations, a subsequent return to work, and with no real policy changes planned, Houston's traffic headaches could soon return.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

Axiom Space tops $525M in oversubscribed round, announces Swiss subsidiary

funding boost

Axiom Space tacked on an additional $175 million to a previously announced capital raise, bringing the oversubscribed round to a total of more than $525 million.

Axiom shared in February that it had secured $350 million in a financing round led by Type One Ventures and Qatar Investment Authority. In the latest release from the company, Axiom reports that Japan-based MUFG Bank Ltd. joined the round as a new investor, in addition to continued participation from existing backers.

The funding will go toward developing the company's commercial space station, known as Axiom Station, and the production of its Axiom Extravehicular Mobility Unit (AxEMU) under its NASA spacesuit contract.

“Investor interest in this round outpaced what we set out to raise, which speaks to the moment we’re in,” Jonathan Cirtain, CEO and president of Axiom Space, said in the news release. “Our partners see what is possible in low-Earth orbit, and they see who is positioned to lead it.”

Axiom announced last month that it planned to open a Japanese subsidiary July 1. Earlier this week, it also shared plans to establish Axiom Space Switzerland, a wholly owned subsidiary based in Lucerne that is also expected to begin operations this summer.

The Switzerland subsidiary aims to establish Axiom's presence in Europe and help it partner with the European Space Agency and other space organizations and companies on the continent.

“Europe is a founding leader in the creation of the commercial space economy, and Switzerland is uniquely positioned to convene the government agencies, research institutions, and industrial entities that will shape its next decade,” Cirtain added in a separate release. “Axiom Space Switzerland facilitates the scaling of development and deployment of the infrastructure that will succeed the International Space Station.”

View All Listings